File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Comparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis

TitleComparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritis
Authors
KeywordsClassification criteria
Disease activity
Functional status
Spondyloarthropathy
Issue Date2011
PublisherSpringer-Verlag London Ltd. The Journal's web site is located at http://link.springer.de/link/service/journals/10067/
Citation
Clinical Rheumatology, 2011, v. 30 n. 7, p. 947-953 How to Cite?
AbstractEarly diagnosis of spondyloarthritis (SpA) is essential as anti-tumor necrosis factor therapy can achieve significant symptomatic relief and control of disease activity. This study aims to compare the clinical characteristics, disease activity, and functional status of a Chinese cohort of SpA patients who were re-classified into ankylosing spondylitis (AS) patients fulfilling the modified New York (MNY) criteria, those with undifferentiated SpA (USpA) fulfilling the European Spondyloarthropathy Study Group (ESSG) classification criteria only (USpA/ESSG) and those who fulfill Assessment of SpondyloArthritis International Society (ASAS) only (USpA/ASAS). Disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), severity of morning stiffness, patient global assessment, and C-reactive protein. Functional status was evaluated by Bath Ankylosing Spondylitis Functional Index (BASFI), modified Schober index, and dimension of chest expansion. One hundred and twenty-eight patients with disease duration of 16.3 ± 10.4 years were recruited. Patients in USpA/ESSG and USpA/ASAS were significantly younger (p = 0.01), had shorter disease duration (p < 0.01), and lower BASFI (p = 0.03) than established AS patients. All three groups have active disease with comparable BASDAI >3. BASFI correlated inversely with dimension of chest expansion and negatively modified Schober index in AS patients (p < 0.01) and modestly with BASDAI (r = 0.25, p < 0.01). BASFI correlated moderately with BASDAI in USpA/ESSG (r = 0.61, p < 0.01) but not with chest expansion or modified Schober index. Compared with established AS patients recognized by MNY criteria, patients fulfilling USpA defined by ESSG or ASAS criteria had earlier disease, as active disease and less irreversible functional deficit. © 2011 The Author(s).
Persistent Identifierhttp://hdl.handle.net/10722/139486
ISSN
2015 Impact Factor: 2.042
2015 SCImago Journal Rankings: 0.697
PubMed Central ID
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChung, HYen_HK
dc.contributor.authorLau, CSen_HK
dc.contributor.authorWu, KPen_HK
dc.contributor.authorWong, WSen_HK
dc.contributor.authorMok, MYen_HK
dc.date.accessioned2011-09-23T05:50:35Z-
dc.date.available2011-09-23T05:50:35Z-
dc.date.issued2011en_HK
dc.identifier.citationClinical Rheumatology, 2011, v. 30 n. 7, p. 947-953en_HK
dc.identifier.issn0770-3198en_HK
dc.identifier.urihttp://hdl.handle.net/10722/139486-
dc.description.abstractEarly diagnosis of spondyloarthritis (SpA) is essential as anti-tumor necrosis factor therapy can achieve significant symptomatic relief and control of disease activity. This study aims to compare the clinical characteristics, disease activity, and functional status of a Chinese cohort of SpA patients who were re-classified into ankylosing spondylitis (AS) patients fulfilling the modified New York (MNY) criteria, those with undifferentiated SpA (USpA) fulfilling the European Spondyloarthropathy Study Group (ESSG) classification criteria only (USpA/ESSG) and those who fulfill Assessment of SpondyloArthritis International Society (ASAS) only (USpA/ASAS). Disease activity was evaluated by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), severity of morning stiffness, patient global assessment, and C-reactive protein. Functional status was evaluated by Bath Ankylosing Spondylitis Functional Index (BASFI), modified Schober index, and dimension of chest expansion. One hundred and twenty-eight patients with disease duration of 16.3 ± 10.4 years were recruited. Patients in USpA/ESSG and USpA/ASAS were significantly younger (p = 0.01), had shorter disease duration (p < 0.01), and lower BASFI (p = 0.03) than established AS patients. All three groups have active disease with comparable BASDAI >3. BASFI correlated inversely with dimension of chest expansion and negatively modified Schober index in AS patients (p < 0.01) and modestly with BASDAI (r = 0.25, p < 0.01). BASFI correlated moderately with BASDAI in USpA/ESSG (r = 0.61, p < 0.01) but not with chest expansion or modified Schober index. Compared with established AS patients recognized by MNY criteria, patients fulfilling USpA defined by ESSG or ASAS criteria had earlier disease, as active disease and less irreversible functional deficit. © 2011 The Author(s).en_HK
dc.languageengen_US
dc.publisherSpringer-Verlag London Ltd. The Journal's web site is located at http://link.springer.de/link/service/journals/10067/en_HK
dc.relation.ispartofClinical Rheumatologyen_HK
dc.rightsThe original publication is available at www.springerlink.com-
dc.rightsThe Author(s)-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.subjectClassification criteriaen_HK
dc.subjectDisease activityen_HK
dc.subjectFunctional statusen_HK
dc.subjectSpondyloarthropathyen_HK
dc.subject.meshActivities of Daily Living-
dc.subject.meshAsian Continental Ancestry Group-
dc.subject.meshHealth Status-
dc.subject.meshSeverity of Illness Index-
dc.subject.meshSpondylitis, Ankylosing - classification - diagnosis - physiopathology-
dc.titleComparison of performance of the Assessment of Spondyloarthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritisen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0770-3198&volume=30&issue=7&spage=947&epage=953&date=2011&atitle=Comparison+of+performance+of+the+Assessment+of+Spondyloarthritis+International+Society,+the+European+Spondyloarthropathy+Study+Group+and+the+modified+New+York+criteria+in+a+cohort+of+Chinese+patients+with+spondyloarthritis-
dc.identifier.emailLau, CS:cslau@hku.hken_HK
dc.identifier.emailMok, MY:temy@hkucc.hku.hken_HK
dc.identifier.authorityLau, CS=rp01348en_HK
dc.identifier.authorityMok, MY=rp00490en_HK
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1007/s10067-011-1693-6en_HK
dc.identifier.pmid21336823-
dc.identifier.pmcidPMC3123457-
dc.identifier.scopuseid_2-s2.0-79959600541en_HK
dc.identifier.hkuros195408en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-79959600541&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume30en_HK
dc.identifier.issue7en_HK
dc.identifier.spage947en_HK
dc.identifier.epage953en_HK
dc.identifier.isiWOS:000292042600009-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridChung, HY=52363495600en_HK
dc.identifier.scopusauthoridLau, CS=14035682100en_HK
dc.identifier.scopusauthoridWu, KP=53983471200en_HK
dc.identifier.scopusauthoridWong, WS=8737892100en_HK
dc.identifier.scopusauthoridMok, MY=7006024184en_HK
dc.identifier.citeulike8946569-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats